Tricyclic pyrazole derivatives as cannabinoid receptor modulators

Details for Australian Patent Application No. 2005278781 (hide)

Owner Cadila Healthcare Limited

Inventors Lohray, Vidya Bhushan; Lohray, Braj Bhushan; Srivastava, Brijesh

Agent Griffith Hack

Pub. Number AU-B-2005278781

PCT Pub. Number WO2006/025069

Priority 745/MUM/2004 12.07.04 IN

Filing date 8 July 2005

Wipo publication date 9 March 2006

Acceptance publication date 18 June 2009

International Classifications

C07D 495/14 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4162 (2006.01) - condensed with heterocyclic ring systems

C07D 231/54 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/025069 Priority application(s): WO2006/025069

18 June 2009 Application Accepted

  Published as AU-B-2005278781

15 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005278782-Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol

2005278780-A purified arabinogalactan-protein (AGP) composition